Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide and semaglutide are both weekly GLP-1 receptor agonists used to treat type 2 diabetes and support weight loss
It acts on kisspeptin receptors in the hypothalamus to increase GnRH secretion, which in turn shapes the timing and amplitude of LH/FSH release
The approval was later upgraded in January of 2023 to allow it to be a first-line option for adults with Type 2 Diabetes
First, PCOS was identified based on the presence of at least one diagnosis code, without requiring that it appear as a primary diagnosis or be confirmed across multiple encounters
US$ 26.94
US$ 28.84
US$ 22.55
US$ 24.40
US$ 20.76
